Published in Auto Immun Highlights on January 13, 2012
Recent advances in the diagnosis and treatment of primary biliary cholangitis. World J Hepatol (2016) 0.79
Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature. Tuberc Res Treat (2012) 0.75
Popular and unpopular infectious agents linked to primary biliary cirrhosis. Auto Immun Highlights (2012) 0.75
The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics. Auto Immun Highlights (2012) 0.75
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Primary biliary cirrhosis. Hepatology (2009) 5.35
The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol (2001) 2.87
Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol (2003) 2.69
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun (2009) 2.49
The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology (2008) 2.32
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (2005) 2.15
Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis (2010) 2.09
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology (2007) 2.08
Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect (1999) 1.95
IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology (2006) 1.91
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology (2006) 1.64
The role of environmental factors in primary biliary cirrhosis. Trends Immunol (2009) 1.61
Infections and autoimmune diseases. J Autoimmun (2005) 1.61
Primary biliary cirrhosis: an epidemiological study. Br Med J (1980) 1.48
Primary biliary cirrhosis. Semin Immunopathol (2009) 1.46
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun (2006) 1.43
Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus (2006) 1.39
Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity (2005) 1.36
Is autoimmunity a matter of sex? Autoimmun Rev (2008) 1.35
Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34
Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology (1987) 1.32
Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut (2004) 1.31
Primary biliary cirrhosis. Orphanet J Rare Dis (2008) 1.31
Light, including ultraviolet. J Autoimmun (2009) 1.28
Primary biliary cirrhosis. Lancet (1997) 1.27
The consequences of apoptosis in autoimmunity. J Autoimmun (2008) 1.24
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol (2002) 1.24
Virus, liver and autoimmunity. Dig Liver Dis (2001) 1.24
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol (2001) 1.21
Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol (1988) 1.21
Bacteriuria and primary biliary cirrhosis. Gut (1984) 1.20
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology (1997) 1.20
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology (2006) 1.15
Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology (2009) 1.14
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect (1999) 1.10
Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett (2000) 1.08
Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut (2010) 1.07
M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol (1993) 1.07
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut (2005) 1.07
Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun (2003) 1.07
Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology (1991) 1.06
Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis (1997) 1.06
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol (2004) 1.06
Pathogenesis of primary biliary cirrhosis. Gut (2007) 1.05
Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology (2000) 1.04
Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect (1999) 1.04
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology (2005) 1.03
Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology (Oxford) (2010) 1.03
Occupational exposures and risk of systemic lupus erythematosus: a review of the evidence and exposure assessment methods in population- and clinic-based studies. Lupus (2006) 1.03
Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta (2010) 1.03
Twin studies in rheumatic diseases. Semin Arthritis Rheum (1994) 1.02
Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis (2009) 1.02
Autoantibodies against "nuclear dots" in primary biliary cirrhosis. Semin Liver Dis (1997) 1.01
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol (2010) 1.01
New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem (2009) 0.99
Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty? J Autoimmun (2009) 0.98
Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol (2005) 0.96
The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers (2010) 0.96
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int (2007) 0.96
Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology (1999) 0.96
Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol (2004) 0.96
Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol (2003) 0.95
Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology (2004) 0.95
Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis (1997) 0.94
Molecular mimicry and primary biliary cirrhosis: premises not promises. Hepatology (2001) 0.94
Antimitochondrial and other autoantibodies. Clin Liver Dis (2003) 0.94
Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol (2009) 0.94
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver (2001) 0.93
Occupational and environmental associations with antinuclear antibodies in a general population sample. J Toxicol Environ Health A (2006) 0.93
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol (2007) 0.93
Drug-induced lupus. Drug Saf (1995) 0.92
Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology (1997) 0.92
Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol (1989) 0.91
Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol (2012) 0.91
Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol (2009) 0.91
Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA - evidence-based immunology? Auto Immun Highlights (2010) 0.91
Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand J Immunol (1997) 0.90
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr Mol Med (2001) 0.90
Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis Rheum (1996) 0.90
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology (2007) 0.90
Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun (2010) 0.88
Autoimmune hepatitis. Semin Immunopathol (2009) 0.88
Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol (2003) 0.88
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol (2004) 0.87
Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr Rheumatol Rep (2004) 0.86
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta (2007) 0.86
Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am J Gastroenterol (2004) 0.86
Management of the antiphospholipid syndrome. Auto Immun Highlights (2010) 0.85
Positive markers in AMA-negative PBC. Am J Gastroenterol (2003) 0.85
Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun (2001) 0.85
CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis. Cell Mol Immunol (2010) 0.85
Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. Hepatology (1999) 0.84
Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol (2002) 0.84
Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s. Curr Med Chem (2008) 0.83
Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver Int (2006) 0.83
Novel antiphospholipid antibodies in autoimmune bullous diseases. Hum Antibodies (2014) 0.75
The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic. Clin Exp Rheumatol (2017) 0.75